Huadong Medicine Co., Ltd
000963
Rankning i aktier
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Aktiekurs
$3.89
Marknadsvärde
$6.83B
Förändring (1 dag)
-2.22%
Förändring (1 år)
-30.58%
Land
CN
Handel Huadong Medicine Co., Ltd (000963)
Kategori
Healthcare
Antal utestående aktier för Huadong Medicine Co., Ltd (000963)
Antal utestående aktier per June 2026: 1.75B
Enligt de senaste finansiella rapporterna och aktiekursen för Huadong Medicine Co., Ltd är det aktuella antalet utestående aktier 1.75B. I slutet av December 2024 hade företaget 1.75B utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Huadong Medicine Co., Ltd (000963) från 2001 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 1.75B | 0.08% |
| 2025 | 1.75B | 0.02% |
| 2024 | 1.75B | 0.02% |
| 2023 | 1.75B | 0.10% |
| 2022 | 1.75B | 0.00% |
| 2021 | 1.75B | 0.00% |
| 2020 | 1.75B | 0.00% |
| 2019 | 1.75B | -0.44% |
| 2018 | 1.76B | 0.42% |
| 2017 | 1.75B | 0.83% |
| 2016 | 1.74B | 11.22% |
| 2015 | 1.56B | -0.30% |
| 2014 | 1.57B | -0.16% |
| 2013 | 1.57B | 0.10% |
| 2012 | 1.57B | 0.37% |
| 2011 | 1.56B | -0.27% |
| 2010 | 1.56B | -0.34% |
| 2009 | 1.57B | 0.88% |
| 2008 | 1.56B | -0.13% |
| 2007 | 1.56B | 12.06% |
| 2006 | 1.39B | -10.76% |
| 2005 | 1.56B | 0.00% |
| 2004 | 1.56B | 0.00% |
| 2003 | 1.56B | 0.00% |
| 2002 | 1.56B | 0.00% |
| 2001 | 1.56B | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 1.56B | -10.90% |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 36.81% |
IN
|
